Contact UsInvestorsCareersMediaContact Us
Investor Relations

STATUTORY COMMUNICATIONS 2022 - 2023

Pfizer Limited – Stock Exchange Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

Pfizer Limited – Annual Secretarial Compliance Report

Disclosure on Related Party Transactions as on March 31, 2023

Pfizer Limited – Notice of closure for Trading Window – March 31, 2023

Pfizer Limited - Update on sale of Thane Business Undertaking to Vidhi Research and Development LLP

Pfizer Limited – Appointment of Meenakshi Nevatia as the Managing Director of Pfizer Limited - February 9, 2023

Pfizer Limited – Notice of the Board Meeting – February 9, 2023

Pfizer Limited – Notice for closure of Trading Window – December 31, 2022

Disclosure on Related Party Transactions as on September 30, 2022

Pfizer Limited – Notice for Board Meeting – November 11, 2022

Pfizer Limited – Notice for closure of Trading Window – September 30, 2022

Declaration of Interim (Special) Dividend – September 6, 2022

Pfizer Limited – Intimation of Record Date – September 20, 2022

Notice of the Board Meeting – September 6, 2022

Pfizer Limited 71st AGM evoting results

Pfizer Limited – Proceedings of the 71st Annual General Meeting

Intimation regarding resignation of Mr. S. Sridhar as the Managing Director of the Company

Important Communication for ShareholdersPfizer Limited Notice of the 71st Annual General Meeting and general information – Business Standard and SakaalPfizer Limited Annual Report and Notice of 71st Annual General Meeting & Record DateUpdate on Sale of Pfizer Limited’s Upjohn Business to Mylan Pharmaceuticals Private LimitedNotice of the Board Meeting – August 5, 2022Pfizer Limited – Change in website of the CompanyPfizer Limited Notice for closure of Trading Window – June 30, 2022Disclosure on Related Party Transactions as on March 31, 2022Profile of Statutory Auditors - M/s. B.S.R & Co LLP, Statutory AuditorsOutcome of Board Meeting – May 20, 2022 – Appointment of Statutory AuditorsNotice of the Board Meeting – May 20, 2022Change in name of Registrar and Share Transfer Agent of the CompanyStock exchange intimation - Declaration of Voluntary Retirement Scheme
About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.